Stock listing

Tokyo:4591 Ribomic, Inc. (リボミック) 株価

Follow Ribomic, Inc. into a list and get an email when it puts out news.

Ribomic, Inc. logo
Ticker
Tokyo:4591
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Tokyo
Currency
JPY

What changed lately

Latest news

RIBOMIC Announces Interim Report on the Phase 2 Long-Term Clinical Trial of Umedaptanib Pegol in the Treatment of Achondroplasia

Oct 6, 2026

[Delayed]RIBOMIC Announces No Safety Concerns After Three Months of 1mg/kg Weekly Treatment with Umedaptanib Pegol in Achondroplasia Phase2 Study

Sep 29, 2026

RIBOMIC Announces Completion of Clinical Trial Site Establishment for the Phase 3 Clinical Trial of Umedaptanib Pegol in Achondroplasia

Aug 24, 2026

Summary of Non-Consolidated Financial Results for the Three Months Ended June 30 2026(Based on Japanese GAAP)

Aug 13, 2026

RIBOMIC Announces First Patient In (FPI) in the Phase 3 Clinical Trial of Umedaptanib Pegol in the Treatment of Achondroplasia

Jul 1, 2026

RIBOMIC Announces Positive Phase 2 Cohort 2 Results for Umedaptanib Pegol in Achondroplasia, Demonstrating an Increase in the Annualized Growth Rate of up to +5.0 cm/year with Biweekly Administration in Children Aged 5 Years and Older

Oct 7, 2025

RIBOMIC Announces Positive Interim Results from Phase IIa Trial of umedaptanib pegol in Achondroplasia Demonstrating Increase in Annualized Growth Rate of up to +4.6 cm/year in Children 5 Years of Age and Older in the Low Dose Cohort

Nov 5, 2024

RIBOMIC Announces Completion of Patient Enrollment in Early Phase II Study of umedaptanib pegol for Achondroplasia and Initiation of Dosing in Cohort 2 of Early Phase II Clinical Study

Aug 3, 2024

RIBOMIC Phase I and II Data Published in the Eye: Full TOFU/RAMEN/TEMPURA Trial Results Demonstrate Clinical Proof of Concept of Umedaptanib Pegol in Exudative Age-Related Macular Degeneration (nAMD)

Dec 5, 2023

RIBOMIC Announces Issuance of US Patent for its RBM-010, Novel Drug Candidate for Osteoarthritis

Jul 29, 2022

All Ribomic, Inc. news

Decks

Ribomic, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
5 in the last 12 months · 28 in all · newest Oct 6, 2026 · oldest 2021
Decks
1 deck · latest Jan 11, 2022

Log in to ask 6ix AI your own questions about Ribomic, Inc.